MYFOCEPT-S 180 JPG
Click to enlarge

Myfocept-S 180

Mycophenolate Sodium Tablets 180 mg

Email Directly
WHO-GMP Certified
Global Export Ready
Quality Assured
Aprazer Healthcare Pvt Ltd

Enquire NOW!



Category:
Description

Myfocept-S 180

Composition: Mycophenolate Sodium -180 mg

Classification: Organ Transplant Medicine

Myfocept S – Safeguarding Transplants, Supporting Lives

Myfocept S is used as an organ transplant medicine, is highly prescribed, and stands out in efficacy, selectivity and targeted action.

Aprazer Healthcare: The Leading Nephrology Medicine Manufacturer

Aprazer Healthcare is the largest manufacturer and exporter of kidney care medicines and organ transplant medicines to South America, Africa, Southeast Asia, and CIS countries.

Why Aprazer Healthcare?

  • • Largest Range of Nephrology Medicine
  • • Global reach – Largest Exporter
  • • World-class manufacturing Infrastructure
  • • International Quality Standards – WHO-GMP certified
  • • Affordable Medicines
  • • Research-driven formulations
  • • Available in 50+ countries

What is Myfocept-S?

It is an antirejection medicine that is widely used for organ transplant care to reduce the risk of organ rejection.

Uses of Myfocept-S

  • • It is used as prophylaxis for Organ rejection.
  • • Post-transplant therapy – Kidney transplant, Liver transplant, Heart transplant
  • • Autoimmune diseases – rheumatoid arthritis

How does Myfocept work?

It suppresses the immune activity of T cells and B cells.

Reduces the immune response.

It increases the body’s acceptance of the transplanted organ.

Benefits

  • • Targeted effect
  • • Better tolerance
  • • Reduces the need for steroids
  • • Reduces the risk of rejection
  • • Improves quality of life
  • • Supports long-term graft survival

Common Side Effects

  • • Skin rashes
  • • GIT upset
  • • Diarrhea
  • • Headache
  • • Anemia
  • • Infections
  • • Stomach pain
  • • Hair fall
  • • Weakness

Serious Side Effects

  • • Bone marrow suppression
  • • Gastrointestinal bleeding
  • • Renal toxicity
  • • Hepatic-toxicity
  • • Risk of severe infection
  • • Risk of malignancy – leukemia, skin cancer
  • • Low platelets – unusual bleeding

Precautions

To be used cautiously used in :

  • • Elderly patients
  • • Bleeding disorders
  • • Liver disorders
  • • Kidney diseases
  • • Active infections

Safety Instructions

  • • Maintain contraception during the treatment.
  • • Avoid live vaccines (MMR, Varicella) due to a compromised immune system.

Contraindications

  • • Should not be used in pregnant women and breastfeeding mothers.
  • • Hypersensitivity or allergic reaction to the drug or its excipients.

Warnings

To be used under medical prescription.

Drug Interactions

  • • Antivirals
  • • Antacids
  • • Proton pump inhibitors
  • • Antibiotics
  • • TB medicines
  • • And Other immune suppressants

Important Monitoring Considerations

Monitor for –

  • • Total blood count
  • • Liver and kidney functions

FAQ

Frequently Asked Questions

Avoid an antacid with Myfocept-S 180 (mycophenolate mofetil). Why?

It reduces drug absorption.
Take with a gap of 4-6 hours.

Is alcohol use safe with Myfocept-S 180 (mycophenolate mofetil)?

It increases strain on the liver.

Why avoid driving with Myfocept-S 180 (mycophenolate mofetil)?

It causes dizziness.

Myfocept-S 180 (mycophenolate mofetil) is harmful in pregnancy. Why?

It is dangerous for the fetus.

Is it safe to break the tablet?

Avoid crushing the medication.
It is toxic.

Do not stop medicine without a doctors advice. Why?

It can trigger rapid organ rejection.

Name the leading company manufacturing anti-rejection medicines?

Aprazer Healthcare is a pharmaceutical manufacturer.
References-
__[__https://medlineplus.gov/druginfo/meds/a601081.html__](https://medlineplus.gov/druginfo/meds/a601081.html)
[__https://pmc.ncbi.nlm.nih.gov/articles/PMC11753233/__](https://pmc.ncbi.nlm.nih.gov/articles/PMC11753233/)
[__https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=721564bc-7c0b-4418-ab49-0af362e74eb7__](https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=721564bc-7c0b-4418-ab49-0af362e74eb7)

Reference Link